Search

Search Results

• Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects

  M. Malerba, B. Ragnoli, M. Corradi

  2016-01-26

  https://doi.org/10.4081/monaldi.2008.390

  819

  PDF: 572
• 

  Comparing the effect of cardiac biomarkers on the outcome of normotensive patients with acute pulmonary embolism

  Yaser Jenab, Marzieh Pourjafari, Maryam Sotoudeh, Masoumeh Lotfi-tokaldany, Nasrin Etesamifard, Shapour Shirani, Arash Jalali, Younes Nozari, Hamid-reza Poorhosseini

  2017-05-18

  https://doi.org/10.4081/monaldi.2017.767

  1506

  PDF: 815
• 

  Cardiac biomarkers and mortality in COVID-19 infection: A review

  Angelica Cersosimo, Giuliana Cimino, Ludovica Amore, Emiliano Calvi, Greta Pascariello, Riccardo Maria Inciardi, Carlo Mario Lombardi, Enrico Vizzardi, Marco Metra

  2022-06-23

  https://doi.org/10.4081/monaldi.2022.2276

  1689

  PDF: 453

• Gaining insights into chronic obstructive pulmonary disease exacerbation through emerging biomarkers and the chronic obstructive pulmonary disease assessment test score

  Megha Hegde, Saurav Raj, Aishwarya S Pattanshetti, Sanatkumar Bharamu Nyamagoud

  2024-03-14

  https://doi.org/10.4081/monaldi.2024.2955

  690

  PDF: 10

• Phenomenology of COPD: interpreting phenotypes with the ECLIPSE study

  Alberto Papi, Maria Sandra Magnoni, Carmelo Caio Muzzio, Gianmarco Benso, Andrea Rizzi

  2016-10-14

  https://doi.org/10.4081/monaldi.2016.721

  2813

  PDF: 1658

• Markers of airway inflammation in pulmonary diseases assessed by induced sputum

  S. Dragonieri, O. Tongoussouva, A. Zanini, A. Imperatori, A. Spanevello

  2016-01-21

  https://doi.org/10.4081/monaldi.2009.357

  1192

  PDF: 577
• 

  Anabolic hormones and heart failure with preserved ejection fraction: looking for Ariadne’s thread

  Mariarosaria De Luca, Giulia Crisci, Federica Giardino, Valeria Valente, Ilaria Amaranto, Olimpia Iacono, Roberta D'Assante, Francesco Giallauria, Alberto M. Marra

  2021-08-03

  https://doi.org/10.4081/monaldi.2021.1743

  2064

  PDF: 793

• PD-L1 and molecular biomarker expression in non-small cell lung cancer in Tunisian patients

  Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Ayadi

  2023-11-03

  https://doi.org/10.4081/monaldi.2023.2778

  904

  PDF: 106

• An in-depth investigation of serum Krebs von den Lungen-6 and other biomarkers in COVID-19 severity and mortality

  Andro Pramana Witarto, Alfian Nur Rosyid, Bendix Samarta Witarto, Shidi Laras Pramudito, Achmad Januar Er Putra

  2024-07-26

  https://doi.org/10.4081/monaldi.2024.2848

  599

  PDF_EARLY VIEW: 170

  SUPPLEMENTARY MATERIAL: 33

• The diagnostic value of inflammatory biomarkers in the diagnosis and treatment of influenza B in adults

  Ayshan Mammadova, Gunel Jeyranova

  2025-04-07

  https://doi.org/10.4081/monaldi.2025.3296

  183

  PDF_EARLY VIEW: 47

• From gastric aspiration to airway inflammation

  I.A. Brownlee, A. Aseeri, C. Ward, J.P. Pearson

  2016-01-19

  https://doi.org/10.4081/monaldi.2010.299

  1227

  PDF: 697

• Cardiovascular risk prediction in the real world. The discouraging evidences coming from literature

  Gian Francesco Mureddu, Pompilio Faggiano, Fausto Rigo

  2015-12-01

  https://doi.org/10.4081/monaldi.2012.112

  1086

  PDF: 973

• Cardiologic evaluation of patients undergoing chemoterapy

  Barbara Bordoni, Stefano Urbinati, Alicia Tosoni, Graziana Labanti, Alba Brandes

  2015-08-20

  https://doi.org/10.4081/monaldi.2014.46

  1325

  PDF: 847

• Evaluation of health-related quality of life in respiratory disease patients in a tertiary care teaching hospital

  Princy Domnic Dsouza, Sai Phalguna Prakash Chitralu, Vinod Ashok Koujalagi, Chandrashekhar Mallikarjun Patil, Sanatkumar Bharamu Nyamagoud, Agadi Hiremath Viswanatha Swamy

  2024-11-28

  https://doi.org/10.4081/monaldi.2024.3146

  593

  PDF: 108
• 

  Suppression of tumorigenicity 2 after exercise: a systematic review

  Ana Martins da Costa, Rafael Teixeira, Eduardo M. Vilela, Ana Tavares, Susana Torres, Francisco Sampaio, Madalena Teixeira, Ricardo Fontes-Carvalho, José Pedro Nunes

  2021-08-10

  https://doi.org/10.4081/monaldi.2021.1839

  1541

  PDF: 600

• Pentraxin-3 as a novel biomarker in predicting outcomes of nosocomial pneumonia: a prospective observational study

  Isha Garg, Nishant Kumar Chauhan, Harsh Vardhan, Shrimanjunath Sankanagoudar, Naveen Dutt, Gopal Durgeshwar, Hariharan Iyer, Nikhil Kothari, Ravisekhar Gadepalli, Deepak Kumar

  2025-06-12

  https://doi.org/10.4081/monaldi.2025.3225

  23

  PDF: 15

• Point-of-care test for tuberculosis: a boon in diagnosis

  Devika Tayal, Prabhpreet Sethi, Prerna Jain

  2023-04-28

  https://doi.org/10.4081/monaldi.2023.2528

  2419

  PDF: 929

• Active versus latent pulmonary tuberculosis: which one is the appropriate distinguishing biomarker?

  Rizk Sayad R. Sarhan, Omnia Y. Habashy, Raafat R. Mohammed, Yasmin M. Marei

  2024-07-25

  https://doi.org/10.4081/monaldi.2024.2947

  495

  PDF_EARLY VIEW: 165

  SUPPLEMENTARY MATERIAL: 36

• Prospective assessment of venous thromboembolism in lung cancer patients using a standardized screening protocol

  Pedro Magalhães Ferreira, Joana Ferreira, Cláudia Freitas, Catarina Sousa, David Araújo, Hélder Novais Bastos, Adriana Magalhães, Maria Gabriela Fernandes

  2025-02-24

  https://doi.org/10.4081/monaldi.2025.3293

  555

  PDF_EARLY VIEW: 175

  SUPPLEMENTARY MATERIAL: 19
• 

  COVID-19: the difference between the nose and the lung

  Matteo Gelardi, Mario Notargiacomo, Eleonora Maria Consiglia Trecca, Michele Cassano, Giorgio Ciprandi

  2021-03-05

  https://doi.org/10.4081/monaldi.2021.1708

  1303

  PDF: 603

• Diagnostic accuracy of cancer ratio and other new parameters in differentiating malignant from benign pleural effusions

  Narendra Kumar Narahari, Nandini Ravula, Rakesh Kodati, Shantveer G Uppin, Saibaba KSS, Bhaskar Kakarla, Paramjyothi Gongati

  2024-12-06

  https://doi.org/10.4081/monaldi.2024.3131

  430

  PDF_EARLY VIEW: 126

  SUPPLEMENTARY MATERIAL: 11
• 

  Homocysteine and atrial fibrillation: novel evidences and insights

  Valeriy Ivanov, Yuliia Smereka, Volodymyr Rasputin, Kostiantyn Dmytriiev

  2022-04-20

  https://doi.org/10.4081/monaldi.2022.2241

  2043

  PDF: 765

• Assessing disease activity in scleroderma-related interstitial lung disease: a review and practical guide to management

  Tochukwu Adizie, Lauren Dolan, Aqusa Zahid, Ahmed Fahim

  2024-09-25

  https://doi.org/10.4081/monaldi.2024.2957

  879

  PDF_EARLY VIEW: 395

• Infective pulmonary diseases and the eye: a narrative review

  Mamta Singh, Kunal Deokar, Bibhuti Prassan Sinha, Jinish Doshi, CDS Katoch

  2024-09-10

  https://doi.org/10.4081/monaldi.2024.2988

  737

  PDF_EARLY VIEW: 325

• Utility of systemic immune-inflammation index as a serum biomarker to differentiate between complicated and simple para-pneumonic effusion

  Nikhil Rajvanshi, Prawin Kumar, Jagdish Prasad Goyal

  2023-09-07

  https://doi.org/10.4081/monaldi.2023.2652

  863

  PDF: 111